Tag: RWE submissions

Governance, Ethics and Compliance Considerations for RWE for Regulatory Submissions The advancement and integration of Real-World Evidence (RWE) in regulatory submissions have created both opportunities and challenges for clinical operations, regulatory affairs, and medical affairs professionals. This article serves as a comprehensive tutorial guide to understanding the governance, ethics, and compliance considerations necessary for the…

Read More “Governance, Ethics and Compliance Considerations for RWE for Regulatory Submissions” »

Statistical Approaches to Strengthen RWE for Regulatory Submissions Real-World Evidence (RWE) is increasingly recognized in regulatory frameworks, particularly in enhancing the development of medicinal products and informing clinical decision-making. As the clinical research landscape evolves, regulatory bodies like the FDA, EMA, and MHRA are advocating for the integration of RWE into the drug approval processes….

Read More “Statistical Approaches to Strengthen RWE for Regulatory Submissions” »

Operationalizing RWE for Regulatory Submissions Across Global Programs Operationalizing RWE for Regulatory Submissions Across Global Programs The integration of Real-World Evidence (RWE) into regulatory submissions has become increasingly pivotal for clinical development strategies across U.S., U.K., and EU markets. This comprehensive guide provides a step-by-step approach to operationalizing RWE for your regulatory submissions, particularly focusing…

Read More “Operationalizing RWE for Regulatory Submissions Across Global Programs” »

How AI and Automation Are Transforming RWE for Regulatory Submissions How AI and Automation Are Transforming RWE for Regulatory Submissions Real-world evidence (RWE) has emerged as a crucial component in the landscape of clinical trials and regulatory submissions. The integration of artificial intelligence (AI) and automation technologies has further enhanced the capabilities of RWE, enabling…

Read More “How AI and Automation Are Transforming RWE for Regulatory Submissions” »

Future Trends: Real-World, Digital and Hybrid Evidence in RWE for Regulatory Submissions The field of clinical trials continues to evolve, particularly with the integration of real-world evidence (RWE), digital methodologies, and hybrid designs into regulatory submissions. This comprehensive guide aims to provide a step-by-step overview of how clinical operations, regulatory affairs, and medical affairs professionals…

Read More “Future Trends: Real-World, Digital and Hybrid Evidence in RWE for Regulatory Submissions” »

Digital Tools and Data Pipelines to Strengthen RWE for Regulatory Submissions Digital Tools and Data Pipelines to Strengthen RWE for Regulatory Submissions In the landscape of modern clinical research, the use of Real-World Evidence (RWE) has gained prominence, particularly for regulatory submissions. As professionals in clinical operations, regulatory affairs, and medical affairs, understanding how to…

Read More “Digital Tools and Data Pipelines to Strengthen RWE for Regulatory Submissions” »

KRIs, KPIs and Quality Metrics to Improve RWE for Regulatory Submissions KRIs, KPIs and Quality Metrics to Enhance Real-World Evidence for Regulatory Submissions Introduction to Real-World Evidence (RWE) in Clinical Trials Real-World Evidence (RWE) represents a significant evolution in clinical trial design and implementation. Unlike traditional clinical trials that often rely on controlled environments and…

Read More “KRIs, KPIs and Quality Metrics to Improve RWE for Regulatory Submissions” »

Case Studies: RWE for Regulatory Submissions That Changed Regulatory or Payer Decisions Introduction to Real-World Evidence in Regulatory Submissions Real-world evidence (RWE) has emerged as a critical component in the regulatory decision-making process for drugs and medical devices. The integration of RWE allows for a more nuanced understanding of the clinical effectiveness, safety, and real-life…

Read More “Case Studies: RWE for Regulatory Submissions That Changed Regulatory or Payer Decisions” »

Integrating RWE for Regulatory Submissions With Clinical Trials, RCTs and Hybrid Designs Real-World Evidence (RWE) has emerged as a pivotal aspect of clinical research psychology, playing a significant role in guiding the design and execution of clinical trials, particularly in terms of regulatory submissions. With the increasing demand for integrating RWE into randomized controlled trials…

Read More “Integrating RWE for Regulatory Submissions With Clinical Trials, RCTs and Hybrid Designs” »

Data Models, Standards and Metadata Needed for Strong RWE for Regulatory Submissions In recent years, real-world evidence (RWE) has gained significant traction in the domain of clinical research, particularly when informing regulatory submissions to agencies like the FDA in the United States, EMA in the European Union, and MHRA in the United Kingdom. This article…

Read More “Data Models, Standards and Metadata Needed for Strong RWE for Regulatory Submissions” »